Abstract Number: 1450 • ACR/ARHP Annual Meeting 2013
Safety Of Resuming The Tumor Necrosis Factor Antagonists Therapy In Patients Who Developed Tuberculosis After Use Of Tumor Necrosis Factor Antagonists
Background/Purpose: Tuberculosis is one of the most serious adverse events related to tumor necrosis factor (TNF) antagonists in inflammatory diseases. However, there is no consensus…
